StockData
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31

Vireo Growth Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026

Market cap
$406.23M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 11, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 11, 2026Before market open$209.30M––
Q1 FY2026
Ended Mar 31, 2026
May 12, 2026Before market open$106.20M––
Q4 FY2025
Ended Dec 31, 2025
Mar 17, 2026Before market open$104.50M––
Q3 FY2025
Ended Sep 30, 2025
Nov 12, 2025Before market open$91.70M––
Q2 FY2025
Ended Jun 30, 2025
Aug 13, 2025Before market open$48.10M––
Q1 FY2025
Ended Mar 31, 2025
May 9, 2025Before market open$24.50M$-0.02–
Q4 FY2024
Ended Dec 31, 2024
Mar 4, 2025Before market open$25.00M––
Q1 FY2023
Ended Mar 31, 2023
Apr 6, 2023After market close–––
Q3 FY2022
Ended Sep 30, 2022
Nov 15, 2022During market hours–––
Q2 FY2022
Ended Jun 30, 2022
Aug 11, 2022Before market open–––
Q1 FY2022
Ended Mar 31, 2022
May 11, 2022Before market open–––

Press releases

Announcements Vireo Growth filed with the SEC